title: About human tumor antigens to be used in immunotherapy.
abstract: The choice of antigens to be used in cancer immunotherapy remains a crucial and difficult issue. This review highlights some properties of the different groups of human tumor antigens recognized by T lymphocytes, focusing on parameters that should influence this choice, such as tumor specificity and level of antigen expression.
authors.affiliation: de Duve Institute and Université catholique de Louvain, B-1200 Brussels, Belgium. sophie.lucas@uclouvain.be
authors.forename: S
authors.initials: S
authors.lastname: Lucas
authors.forename: P G
authors.initials: PG
authors.lastname: Coulie
mesh_terms: D000951:Antigens, Neoplasm / Q000276:immunology*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007167:Immunotherapy; D009154:Mutation; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
chemical_list: D000951:Antigens, Neoplasm